What Guardant Health (GH) Said on Its Q3 Earnings Call
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
Guardant Health (NASDAQ:GH) raised its full-year 2026 revenue forecast after third-quarter sales increased 36%, driven by growth in its oncology testing business and demand for its Shield blood-based cancer screening test. The company reported revenue of $361 million for the
Directly affected
- GH Guardant Health-5.9% 8d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Guardant Health belongs to, so it often moves with news about it.
- NTRA Natera-0.5% 30d
Natera is a peer of Guardant Health in medical laboratories; rivals often move on the same news.
- LH Labcorp Holdings+19.1% 30d
Labcorp Holdings is a peer of Guardant Health in medical laboratories; rivals often move on the same news.
- DGX Quest Diagnostics+8.1% 30d
Quest Diagnostics is a peer of Guardant Health in medical laboratories; rivals often move on the same news.
- CAI Caris Life Sciences+10.8% 30d
Caris Life Sciences is a peer of Guardant Health in medical laboratories; rivals often move on the same news.
- GRAL Grail+78.0% 7d
Grail is a peer of Guardant Health in medical laboratories; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| GH | +16.63% | +14.13% | base | after close | after close | after close | after close |
| XLV | -0.05% | -0.52% | base | after close | after close | after close | after close |
| NTRA | +13.85% | +6.81% | base | after close | after close | after close | after close |
| LH | -0.36% | -2.53% | base | after close | after close | after close | after close |
| DGX | -1.10% | -3.12% | base | after close | after close | after close | after close |
| CAI | +31.65% | +26.01% | base | after close | after close | after close | after close |
| GRAL | +20.74% | +17.50% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
What Guardant Health (GH) Said on Its Q3 Earnings Call Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| CAI | three days earlier | +26.01% | final price |
| CAI | five days earlier | +31.65% | final price |
| DGX | three days earlier | -3.12% | final price |
| DGX | five days earlier | -1.10% | final price |
| GH | three days earlier | +14.13% | final price |
| GH | five days earlier | +16.63% | final price |
| GRAL | three days earlier | +17.50% | final price |
| GRAL | five days earlier | +20.74% | final price |
| LH | three days earlier | -2.53% | final price |
| LH | five days earlier | -0.36% | final price |
| NTRA | three days earlier | +6.81% | final price |
| NTRA | five days earlier | +13.85% | final price |
| XLV | three days earlier | -0.52% | final price |
| XLV | five days earlier | -0.05% | final price |
Congressional trades in the stocks in this story
- Rep. Jonathan Jackson bought Guardant Health (GH) (jointly held), worth $15,001 - $50,000 on 28 Sep 2026. That is 39 days before publication. Filed 19 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Labcorp Holdings (LH) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 63 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. April McClain Delaney sold Labcorp Holdings (LH) (held by a dependent child), worth $100,001 - $250,000 on 25 Aug 2026. That is 73 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Quest Diagnostics (DGX) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 63 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
How solid “What Guardant Health (GH) Said on Its Q3 Earnings Call” looks
12 out of 100
“What Guardant Health (GH) Said on Its Q3 Earnings Call” scores 12 out of 100. The score uses 1 sources.